Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER J OLDFIELD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1073512877
CMS profile
48142
Location
SAVANNAH, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,527.85

113 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,527.85 113

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER J OLDFIELD

NPI 1073512877 · CMS profile ID 48142

Allopathic & Osteopathic Physicians / Family Medicine

SAVANNAH, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073512877?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER J OLDFIELD, NPI 1073512877, CMS profile ID 48142. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073512877?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHRISTOPHER J OLDFIELD, NPI 1073512877, CMS profile ID 48142. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073512877?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHRISTOPHER J OLDFIELD, NPI 1073512877, CMS profile ID 48142, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1073512877?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

113 matching records · $1,527.85 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 113 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–113 of 113.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $11.0203/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898936965 CMS
ABBVIE INC. $5.2302/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891284017 CMS
Merck Sharp & Dohme LLC $18.8002/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944277871 CMS
Novartis Pharmaceuticals Corporation $14.8202/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894041499 CMS
Novo Nordisk Inc $14.8002/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898571449 CMS
Amgen Inc. $6.2102/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939174049 CMS
Amgen Inc. $5.5102/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939174047 CMS
Novo Nordisk Inc $14.6402/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898840201 CMS
Amgen Inc. $8.8801/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939174045 CMS
Amgen Inc. $6.3001/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939174043 CMS
Amgen Inc. $13.1901/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939174041 CMS
ABBVIE INC. $15.6601/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891284013 CMS
ABBVIE INC. $11.5401/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891284015 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,818.76 131
PY2020 $1,305.88 94
PY2021 $1,818.73 108
PY2022 $1,527.85 113
PY2023 $1,930.06 133
PY2024 $1,278.22 80
PY2025 $1,373.63 80

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $903,427.86 44
PY2024 Principal investigator $1,029,906.75 16
PY2023 Principal investigator $295,576.70 25
PY2022 Principal investigator $1,161,701.24 52
PY2021 Principal investigator $2,092,757.87 42
PY2020 Principal investigator $833,996.44 11
PY2019 Principal investigator $52,588.71 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

44 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $809.25 09/15/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003105
Principal investigator 1 ModernaTX, Inc. $197.60 08/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003119
Principal investigator 1 Eli Lilly and Company $255,825.60 08/26/2025 Non-covered Recipient Entity
JAVARA
A MASTER PROTOCOL TO INVESTIGATE THE EFFICACY AND SAFETY OF ORFORGLIPRON TABLET ONCE DAILY COMPARED WITH PLACEBO IN PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITH AND WITHOUT TYPE 2 DIABETES: J2A-MC-GZP1, J2A-MC-GZP2 No dispute reported 06/30/2026 1187885216
Principal investigator 1 Eli Lilly and Company $2,208.80 08/12/2025 Non-covered Recipient Entity
JAVARA
A MASTER PROTOCOL TO INVESTIGATE THE EFFICACY AND SAFETY OF ORFORGLIPRON TABLET ONCE DAILY COMPARED WITH PLACEBO IN PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITH AND WITHOUT TYPE 2 DIABETES No dispute reported 06/30/2026 1187882998
Principal investigator 1 ModernaTX, Inc. $46.80 07/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003095
Principal investigator 1 ModernaTX, Inc. $4,199.00 07/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003101
Principal investigator 1 ModernaTX, Inc. $1,200.00 07/14/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003123
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,400.00 07/03/2025 Non-covered Recipient Entity
FELLOWS RESEARCH ALLIANCE INC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945698
Principal investigator 1 ModernaTX, Inc. $57,636.80 06/18/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003099
Principal investigator 1 ModernaTX, Inc. $34,086.00 05/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003107
Principal investigator 1 ModernaTX, Inc. $94,435.68 05/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003153
Principal investigator 1 ModernaTX, Inc. $6,049.04 05/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003157
Principal investigator 1 ModernaTX, Inc. $682.50 05/07/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003129
Principal investigator 1 ModernaTX, Inc. $650.00 05/07/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003133
Principal investigator 1 ModernaTX, Inc. $10,585.82 04/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003103
Principal investigator 1 ModernaTX, Inc. $29,481.92 04/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003147
Principal investigator 1 ModernaTX, Inc. $26,158.24 04/28/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003159
Principal investigator 1 ModernaTX, Inc. $1,105.00 04/23/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003139
Principal investigator 1 ModernaTX, Inc. $325.00 04/23/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003143
Principal investigator 1 ModernaTX, Inc. $800.00 04/23/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003151
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,700.00 04/23/2025 Non-covered Recipient Entity
FELLOWS RESEARCH ALLIANCE INC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945190
Principal investigator 1 Eli Lilly Export S.A. Puerto Rico Branch $8,515.99 04/22/2025 Non-covered Recipient Entity
JAVARA
A MASTER PROTOCOL TO INVESTIGATE THE EFFICACY AND SAFETY OF ORFORGLIPRON TABLET ONCE DAILY COMPARED WITH PLACEBO IN PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITH AND WITHOUT TYPE 2 DIABETES: J2A-MC-GZP1, J2A-MC-GZP2 No dispute reported 06/30/2026 1187883000
Principal investigator 1 ModernaTX, Inc. $325.00 04/02/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003117
Principal investigator 1 ModernaTX, Inc. $31,299.84 03/24/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003089
Principal investigator 1 ModernaTX, Inc. $22,683.90 03/24/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003111
Principal investigator 1 ModernaTX, Inc. $9,310.56 03/24/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003113
Principal investigator 1 ModernaTX, Inc. $1,012.08 03/24/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003127
Principal investigator 1 ModernaTX, Inc. $29,942.25 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003091
Principal investigator 1 ModernaTX, Inc. $2,702.18 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003093
Principal investigator 1 ModernaTX, Inc. $31,757.46 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003109
Principal investigator 1 ModernaTX, Inc. $1,921.97 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003115
Principal investigator 1 ModernaTX, Inc. $35,153.04 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003135
Principal investigator 1 ModernaTX, Inc. $65,617.28 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003145
Principal investigator 1 ModernaTX, Inc. $3,036.24 02/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003155
Principal investigator 1 ModernaTX, Inc. $3,500.00 01/30/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003141
Principal investigator 1 ModernaTX, Inc. $21,795.28 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003097
Principal investigator 1 ModernaTX, Inc. $18,915.26 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003121
Principal investigator 1 ModernaTX, Inc. $24,196.16 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003125
Principal investigator 1 ModernaTX, Inc. $1,921.97 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003131
Principal investigator 1 ModernaTX, Inc. $19,064.48 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003137
Principal investigator 1 ModernaTX, Inc. $1,656.75 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003149
Principal investigator 1 ModernaTX, Inc. $14,169.12 01/27/2025 Non-covered Recipient Entity
JAVARA INC
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253003161
Principal investigator 1 Vanda Pharmaceuticals Inc. $4,000.00 01/22/2025 Non-covered Recipient Entity
FELLOWS RESEARCH ALLIANCE INC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944568
Principal investigator 1 AstraZeneca Pharmaceuticals LP $19,348.00 01/15/2025 Non-covered Recipient Entity
JAVARA, INC
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older No dispute reported 06/30/2026 1185551369